Nidufexor
An overview of the drug Nidufexor
| Nidufexor | |
|---|---|
| [[File:|frameless|220px|alt=|]] | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Overview[edit | edit source]
Nidufexor is a pharmaceutical compound that acts as a selective agonist of the farnesoid X receptor (FXR). It is being investigated for its potential therapeutic effects in the treatment of non-alcoholic steatohepatitis (NASH) and other liver-related disorders. FXR is a nuclear receptor that plays a crucial role in the regulation of bile acid homeostasis, lipid metabolism, and glucose metabolism.
Mechanism of Action[edit | edit source]
Nidufexor functions by activating the farnesoid X receptor, which is predominantly expressed in the liver and intestines. Activation of FXR by Nidufexor leads to a cascade of biological effects, including the suppression of bile acid synthesis, reduction of hepatic triglyceride accumulation, and improvement in insulin sensitivity. These effects make Nidufexor a promising candidate for the treatment of metabolic liver diseases.
Clinical Development[edit | edit source]
Nidufexor is currently undergoing clinical trials to evaluate its efficacy and safety in patients with non-alcoholic steatohepatitis. The drug's ability to modulate FXR activity is being closely studied to determine its potential benefits in reducing liver inflammation and fibrosis, which are key pathological features of NASH.
Potential Benefits[edit | edit source]
The activation of FXR by Nidufexor has several potential therapeutic benefits:
- Reduction of Liver Fat: By decreasing hepatic triglyceride levels, Nidufexor may help reduce liver fat accumulation, a hallmark of NASH.
- Anti-inflammatory Effects: FXR activation can lead to decreased expression of pro-inflammatory cytokines, potentially reducing liver inflammation.
- Fibrosis Reduction: Nidufexor may help in reducing liver fibrosis by modulating pathways involved in fibrogenesis.
Side Effects[edit | edit source]
As with any investigational drug, Nidufexor may have side effects. Commonly observed side effects in clinical trials include gastrointestinal disturbances, pruritus, and changes in lipid profiles. Ongoing studies aim to further elucidate the safety profile of Nidufexor.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
